WallStSmart

Covista Inc. (CVSA)vsMynd.ai, Inc. (MYND)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 1037% more annual revenue ($1.91B vs $167.93M). CVSA leads profitability with a 12.3% profit margin vs -32.2%. CVSA earns a higher WallStSmart Score of 56/100 (C).

CVSA

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 7.5Value: 6.3Quality: 6.5
Piotroski: 6/9Altman Z: 3.09

MYND

Avoid

26

out of 100

Grade: F

Growth: 2.7Profit: 4.0Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: -3.96

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.888/10

Growing faster than its price suggests

MYND2 strengths · Avg: 10.0/10
Return on EquityProfitability
109.4%10/10

Every $100 of equity generates 109 in profit

Debt/EquityHealth
-3.8110/10

Conservative balance sheet, low leverage

Areas to Watch

CVSA2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

EPS GrowthGrowth
-24.6%2/10

Earnings declined 24.6%

MYND4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$19.14M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-34.7%2/10

Revenue declined 34.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : MYND

The strongest argument for MYND centers on Return on Equity, Debt/Equity.

Bear Case : CVSA

The primary concerns for CVSA are Revenue Growth, EPS Growth.

Bear Case : MYND

The primary concerns for MYND are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

CVSA profiles as a value stock while MYND is a turnaround play — different risk/reward profiles.

MYND carries more volatility with a beta of 4.04 — expect wider price swings.

CVSA is growing revenue faster at 4.5% — sustainability is the question.

CVSA generates stronger free cash flow (166M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (56/100 vs 26/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Mynd.ai, Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

MYnd Analytics, Inc. is a predictive analytics company primarily in the United States. The company is headquartered in Mission Viejo, California.

Visit Website →

Want to dig deeper into these stocks?